Tower Research Capital (TRC)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $134K | Sell |
|
|||||
|
2025
Q2 | $270K | Buy |
|
|||||
|
2025
Q1 | $9.07K | Sell |
|
|||||
|
2024
Q4 | $553K | Buy |
|
|||||
|
2024
Q3 | $154K | Sell |
|
|||||
|
2024
Q2 | $281K | Buy |
|
|||||
|
2024
Q1 | $19.1K | Sell |
|
|||||
|
2023
Q4 | $104K | Buy |
|
|||||
|
2023
Q3 | $39.2K | Sell |
|
|||||
|
2023
Q2 | $168K | Sell |
|
|||||
|
2023
Q1 | $331K | Buy |
|
|||||
|
2022
Q4 | $83K | Sell |
|
|||||
|
2022
Q3 | $322K | Buy |
|
|||||
|
2022
Q2 | $78K | Sell |
|
|||||
|
2022
Q1 | $354K | Buy |
|
|||||
|
2021
Q4 | $84K | Sell |
|
|||||
|
2021
Q3 | $111K | Buy |
|
|||||
|
2021
Q2 | $45K | Sell |
|
|||||
|
2021
Q1 | $67K | Buy |
|
|||||
|
2020
Q4 | $30K | Sell |
|
|||||
|
2020
Q3 | $489K | Buy |
|
|||||
|
2020
Q2 | $97K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $56K | Buy |
|
|||||
|
2019
Q3 | $27K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $21K | Buy |
|
|||||
|
2018
Q3 | $2K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $8K | Sell |
|
|||||
|
2017
Q4 | $49K | Sell |
|
|||||
|
2017
Q3 | $38K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2K | Sell |
|
|||||
|
2016
Q4 | $9K | Buy |
|
|||||
|
2016
Q3 | $8K | Sell |
|
|||||
|
2016
Q2 | $40K | Buy |
|
|||||
|
2016
Q1 | $5K | Buy |
|
|||||
|
2015
Q4 | $4K | Sell |
|
|||||
|
2015
Q3 | $24K | Buy |
|
|||||
|
2015
Q2 | $0 | Sell |
|
|||||
|
2015
Q1 | $19K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1K | Sell |
|
|||||
|
2013
Q4 | $32K | Buy |
|